Emily’s Entourage’s Translational Grants

The objective of this initiative is to fund promising therapies and drug-delivery mechanisms that have the potential to accelerate the development of gene-based therapies for people with CF.

For the 2026 cycle, EE will prioritize proposals that turn decisively toward clinical development.

Funding: $100, 000 per year

Duration: 2 years

Research Authority due date: 8.11.26